Anti-sedative could alleviate cancer therapy side effects, study suggests (Flumazenil)

Please feel free to read, share your thoughts, your stories and connect with others!
Posts: 109
Joined: Fri Aug 11, 2023 1:10 am
Facebook Username: CoolHandLukeNone

Anti-sedative could alleviate cancer therapy side effects, study suggests (Flumazenil)

Postby CoolHandLuke8723 » Fri Oct 13, 2023 12:17 am

"Researchers in China have discovered that inhibiting a protein called the GABAA receptor can protect intestinal stem cells from the toxic effects of chemotherapy and radiotherapy.
The study suggests that the FDA-approved anti-sedative flumazenil, which targets GABAA receptors, could alleviate some of the common gastrointestinal side effects, such as diarrhea and vomiting, induced by many cancer treatments.

Because they have to continually proliferate and replace the cells lining the wall of the gut, intestinal stem cells are highly sensitive to chemotherapy and radiotherapy. These treatments damage the DNA of intestinal stem cells and cause them to die, leading to intestinal injury and a variety of painful gastrointestinal symptoms. These toxic side effects, which can persist long after treatment is finished, limit the drug or radiation dose that can be given to cancer patients and worsen their quality of life.

Chen and colleagues found that inhibiting the GABAA receptor protects intestinal stem cells from DNA damage by limiting the formation of free radicals in response to chemoradiotherapy. Crucially, however, the researchers determined that inhibiting the GABAA receptor does not prevent radiation or chemotherapy drugs from killing cancer cells.
Flumazenil is a cheap, GABAA receptor inhibitor approved by the U.S. Food and Drug Administration to treat benzodiazepine overdoses and reverse anesthesia. Chen and colleagues found that flumazenil was also able to protect the intestines of mice from the toxic effects of chemoradiotherapy. Moreover, flumazenil also protected human colonic organoids—miniature organs grown in the lab from human colonic stem cells—from chemotherapy drugs and irradiation.

"Taken together, our data suggest that inhibiting the GABAA receptor is a promising strategy to specifically protect the intestine from chemoradiotherapy," Chen says. "Future studies are required to investigate the pharmacodynamics and tolerability of flumazenil in cancer patients undergoing treatment in the clinic." ... -side.html

Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”

Who is online

Users browsing this forum: Google [Bot] and 79 guests